Targeted DEK depletion in SPOP-Y87N cells reduces sphere-forming ability 112, highlighting DEK's critical role in SPOP-mutant PCa and suggesting a potential therapeutic target. The gene discussed is SPOP; the disease is posterior cortical atrophy.